Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511]

F Miglietta; A Fabi; D Generali; M V Dieci; G Arpino; G Bianchini; S Cinieri; P F Conte; G Curigliano; M De Laurentiis; L Del Mastro; S De Placido; A Gennari; F Puglisi; A Zambelli; F Perrone; V Guarneri

doi:10.1016/j.ctrv.2023.102594

Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511]

Cancer Treat Rev. 2023 Sep:119:102594. doi: 10.1016/j.ctrv.2023.102594. Epub 2023 Jul 1.

Authors

F Miglietta¹, A Fabi², D Generali³, M V Dieci¹, G Arpino⁴, G Bianchini⁵, S Cinieri⁶, P F Conte⁷, G Curigliano⁸, M De Laurentiis⁹, L Del Mastro¹⁰, S De Placido⁴, A Gennari¹¹, F Puglisi¹², A Zambelli¹³, F Perrone¹⁴, V Guarneri¹⁵

Affiliations

¹ Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy; Oncology Unit 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
² Precision Medicine in Breast Cancer, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy.
³ Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Italy.
⁴ Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
⁵ Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy.
⁶ Oncologia Medica, Ospedale Senatore Antonio Perrino, Brindisi, Italy.
⁷ Rete Oncologica Veneta (ROV), Istituto Oncologico Veneto, Italy.
⁸ Department of Oncology and Hemato-Oncology, University of Milano, Italy; Division of Early Drug Development, European Institute of Oncology, Milano, Italy.
⁹ Department of Breast and Thoracic Oncology, National Cancer Institute, IRCCS "Fondazione G. Pascale", Naples, Italy.
¹⁰ Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Italy.
¹¹ Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
¹² Department of Medicine, University of Udine, Udine, Italy; Department of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy.
¹³ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
¹⁴ Clinical Trials Unit, National Cancer Institute, IRCCS "Fondazione G. Pascale", Naples, Italy.
¹⁵ Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy; Oncology Unit 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy. Electronic address: valentina.guarneri@unipd.it.

PMID: 37400291
DOI: 10.1016/j.ctrv.2023.102594

No abstract available

Publication types

Published Erratum